Medtronic plc (MDT) stock
MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 17/303% above fair value
$102.86+1.87 (+1.85%)
Close on Nov 13, 2026Market cap $131.57BP/E 25.3Yield 2.76%
Medtronic total assets
Total assets on the balance sheet at the end of each period.
Medtronic's total assets was $93.31B at Jul 31, 2026. For fiscal 2026 it was $93.03B, up 1.5% from the year before. Over ten years it grew -0.7% a year on average. The highest annual figure on record is $106.69B in fiscal 2015.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Apr 24, 2026 | $93.03B | +1.5% |
| FY2025 | Apr 25, 2025 | $91.68B | +1.9% |
| FY2024 | Apr 26, 2024 | $89.98B | -1.1% |
| FY2023 | Apr 28, 2023 | $90.95B | -0.0% |
| FY2022 | Apr 29, 2022 | $90.98B | -2.3% |
| FY2021 | Apr 30, 2021 | $93.08B | +2.6% |
| FY2020 | Apr 24, 2020 | $90.69B | +1.1% |
| FY2019 | Apr 26, 2019 | $89.69B | -1.9% |
| FY2018 | Apr 27, 2018 | $91.39B | -8.5% |
| FY2017 | Apr 28, 2017 | $99.86B | +0.2% |
| FY2016 | Apr 29, 2016 | $99.64B | -6.6% |
| FY2015 | Apr 24, 2015 | $106.69B | +181.2% |
| FY2014 | Apr 25, 2014 | $37.94B | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jul 31, 2026 | $93.31B | +2.6% |
| Q4 FY2026CQ1 2026 | Apr 24, 2026 | $93.03B | +1.5% |
| Q3 FY2026CQ4 2025 | Jan 23, 2026 | $91.49B | +1.7% |
| Q2 FY2026CQ3 2025 | Oct 24, 2025 | $91.35B | +1.4% |
| Q1 FY2026CQ2 2025 | Jul 25, 2025 | $90.97B | +1.4% |
| Q4 FY2025CQ1 2025 | Apr 25, 2025 | $91.68B | +1.9% |
| Q3 FY2025CQ4 2024 | Jan 24, 2025 | $89.97B | -1.0% |
| Q2 FY2025CQ3 2024 | Oct 25, 2024 | $90.04B | -0.0% |
| Q1 FY2025CQ2 2024 | Jul 26, 2024 | $89.75B | -1.1% |
| Q4 FY2024CQ1 2024 | Apr 26, 2024 | $89.98B | -1.1% |
| Q3 FY2024CQ4 2023 | Jan 26, 2024 | $90.84B | -3.5% |
| Q2 FY2024CQ3 2023 | Oct 27, 2023 | $90.09B | -3.4% |
| Q1 FY2024CQ2 2023 | Jul 28, 2023 | $90.78B | +1.0% |
| Q4 FY2023CQ1 2023 | Apr 28, 2023 | $90.95B | -0.0% |
| Q3 FY2023CQ4 2022 | Jan 27, 2023 | $94.13B | +2.5% |
| Q2 FY2023CQ3 2022 | Oct 28, 2022 | $93.24B | +1.6% |
| Q1 FY2023CQ2 2022 | Jul 29, 2022 | $89.91B | -2.1% |
| Q4 FY2022CQ1 2022 | Apr 29, 2022 | $90.98B | -2.3% |
| Q3 FY2022CQ4 2021 | Jan 28, 2022 | $91.80B | -5.6% |
| Q2 FY2022CQ3 2021 | Oct 29, 2021 | $91.76B | -4.3% |
| Q1 FY2022CQ2 2021 | Jul 30, 2021 | $91.80B | -2.2% |
| Q4 FY2021CQ1 2021 | Apr 30, 2021 | $93.08B | +2.6% |
| Q3 FY2021CQ4 2020 | Jan 29, 2021 | $97.27B | +4.8% |
| Q2 FY2021CQ3 2020 | Oct 30, 2020 | $95.89B | +5.3% |
| Q1 FY2021CQ2 2020 | Jul 31, 2020 | $93.91B | +2.9% |
| Q4 FY2020CQ1 2020 | Apr 24, 2020 | $90.69B | +1.1% |
| Q3 FY2020CQ4 2019 | Jan 24, 2020 | $92.82B | +4.6% |
| Q2 FY2020CQ3 2019 | Oct 25, 2019 | $91.05B | +3.3% |
| Q1 FY2020CQ2 2019 | Jul 26, 2019 | $91.27B | +1.7% |
| Q4 FY2019CQ1 2019 | Apr 26, 2019 | $89.69B | -1.9% |
| Q3 FY2019CQ4 2018 | Jan 25, 2019 | $88.73B | -7.4% |
| Q2 FY2019CQ3 2018 | Oct 26, 2018 | $88.15B | -6.7% |
| Q1 FY2019CQ2 2018 | Jul 27, 2018 | $89.72B | -10.5% |
| Q4 FY2018CQ1 2018 | Apr 27, 2018 | $91.39B | -8.5% |
| Q3 FY2018CQ4 2017 | Jan 26, 2018 | $95.80B | -1.8% |
| Q2 FY2018CQ3 2017 | Oct 27, 2017 | $94.46B | -4.0% |
| Q1 FY2018CQ2 2017 | Jul 28, 2017 | $100.25B | – |
| Q4 FY2017CQ1 2017 | Apr 28, 2017 | $99.86B | – |
| Q3 FY2017CQ4 2016 | Jan 27, 2017 | $97.58B | – |
| Q2 FY2017CQ3 2016 | Oct 28, 2016 | $98.41B | – |
See a number that looks wrong?